| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $768K | +62.0% |
| Cost of Revenue | $756K | +170.9% |
| Gross Profit | $12K | -93.8% |
| R&D Expense | $8.3M | -23.5% |
| SG&A Expense | $5.7M | -21.6% |
| Operating Income | -$18.4M | +16.7% |
| Interest Expense | $200K | — |
| Income Tax | $0 | — |
| Net Income | -$18.4M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.4M | -90.3% |
| Accounts Receivable | $78K | -23.2% |
| Inventory | $498K | +15.9% |
| Current Assets | $2.9M | -80.6% |
| Total Assets | $3.8M | -77.2% |
| Current Liabilities | $4.9M | +5.4% |
| Total Liabilities | $4.9M | -5.9% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$17.6M | +8.7% |
| Capital Expenditures | $123K | -34.3% |
| Investing Cash Flow | -$123K | +34.3% |
| Financing Cash Flow | $5.1M | -27.8% |
| Free Cash Flow | -$17.7M | +9.0% |
| +5.0% |
| EPS (Basic) | -$2.57 | +38.1% |
| EPS (Diluted) | -$2.57 | +38.1% |
| Stockholders' Equity |
| -$1.1M |
| -109.4% |